Document:

EX-10.1

Exhibit 10.1

CRM HOLDINGS, LTD.

and its Subsidiaries

Employment Agreement for Chester J. Walczyk

CRM HOLDINGS, LTD. and its Subsidiaries

Employment Agreement for Chester J. Walczyk

	 	 	 	 	 	 	 	 	 
	 	1.	 	 	Term
	 	 	1	 
	 	2.	 	 	Position, Duties and Responsibilities
	 	 	1	 
	 	3.	 	 	Base Salary
	 	 	2	 
	 	4.	 	 	Incentive Awards
	 	 	2	 
	 	5.	 	 	Other Payments
	 	 	2	 
	 	6.	 	 	Employee Benefit Programs
	 	 	2	 
	 	7.	 	 	Disability
	 	 	2	 
	 	8.	 	 	Reimbursement of Business and Other Expenses
	 	 	2	 
	 	9.	 	 	Termination of Employment
	 	 	3	 
	 	10.	 	 	Confidentiality; Litigation Cooperation; Non-disparagement
	 	 	7	 
	 	11.	 	 	Non-competition
	 	 	8	 
	 	12.	 	 	Non-solicitation
	 	 	9	 
	 	13.	 	 	Remedies
	 	 	9	 
	 	14.	 	 	Resolution of Disputes
	 	 	9	 
	 	15.	 	 	Indemnification
	 	 	9	 
	 	16.	 	 	Miscellaneous
	 	 	10	 

EMPLOYMENT AGREEMENT

AGREEMENT, made and entered into as of the 1st day of January, 2010 (“Effective Date”) by and
between CRM Holdings, Ltd., a Bermuda company (together with its subsidiaries from time to time and
its successors and assigns, “CRM” or “Company”), and Chester J. Walczyk (the “Executive”).

W I T N E S S E T H:

WHEREAS, CRM desires to employ Executive and Executive desires to accept such employment,
pursuant to an agreement embodying the terms of such employment (this “Agreement”).

NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein and for
other good and valuable consideration, the receipt of which is mutually acknowledged, CRM and
Executive (individually a “Party” and together the “Parties”) agree to be bound in accordance with
the terms of this Agreement.

1. Term.

(a) The term of Executive’s employment under this Agreement shall commence on Effective
Date and end on the December 31, 2012 (the “Original Term”), unless terminated earlier in
accordance herewith. The Original Term shall be automatically renewed for successive one-year terms
(the “Renewal Terms”) unless at least 30 days prior to the expiration of the Original Term or any
Renewal Term, either Party notifies the other Party in writing that he or it is electing to
terminate this Agreement at the expiration of the then current Term. “Term” shall mean the
Original Term and all Renewal Terms.

(b) Employment Agreement effective January 1, 2007 between CRM and Executive is hereby
terminated and accordingly shall no longer remain in full force and effect.

2. Position, Duties and Responsibilities.

(a) Generally. Executive shall serve as Chief Operating Officer (“COO”) of CRM. In such
capacity, Executive shall report to the Chief Executive Officer. Executive shall have and perform
such duties, responsibilities, and authorities as are customary for the chief operating officer of
similar size companies and businesses as CRM, as are consistent with such positions and status.
Executive shall devote substantially all of his business time and attention (except for periods of
vacation or absence due to illness), and his best efforts, abilities, experience, and talent to the
position of Chief Operating Officer of CRM.

(b) Other Activities. During the Term, Executive may (i) serve on the boards of directors
of trade associations and/or charitable organizations, provided that Executive shall notify the
Chief Executive Officer of any such position, (ii) engage in charitable activities and community
affairs, and (iii) manage personal investments and affairs, provided that such activities described
in clauses (i), (ii), and (iii) do not materially interfere with the proper performance of his
duties as Chief Operating Officer of CRM. or result in a breach of this Employment Agreement.

(c) Place of Employment. Executive’s principal place of employment shall be the corporate
offices of CRM.

3. Base Salary.

Executive shall be paid an annualized salary (“Base Salary”) of $300,000, in accordance with
CRM’s normal pay practices. The Base Salary shall be reviewed by the Compensation Committee (the
“Compensation Committee”) of the Board of Directors (the “Board”) no less than annually.

4. Incentive Awards.

Executive shall be eligible to participate in CRM’s annual incentive compensation plan with a
target annual incentive award opportunity of 50% of Base Salary (“Annual Incentive”) and a maximum
bonus opportunity of no less than 75%, based upon Company profitability, stock price and
performance criteria as determined by the Compensation Committee on an annual basis. The
Compensation Committee, in their sole discretion, may pay any portion of the Annual Incentive in
cash, restricted stock, or a combination thereof.

5. Other Payments.

(a) Car Allowance. Executive shall receive a $1000.00 a month car allowance, to cover or
contribute toward the cost of owning, operating, maintaining and insuring a motor vehicle of his
choosing.

(b) Vacation. Executive shall be entitled to five (5) weeks of paid vacation annually and
shall take holidays in accordance with CRM’s standard holiday schedule as amended from time to
time.

6. Employee Benefit Programs.

During the Term, Executive shall be entitled to participate in CRM’s employee benefit plans
and programs as such plans or programs may be in effect from time to time, including, without
limitation, health, medical and dental coverage (together, “Welfare Benefits”).

7. Disability.

During any period that Executive fails to perform his duties hereunder as a result of
incapacity due to physical or mental illness (“Disability Period”), Executive shall continue to
receive his full base salary set forth in Section 3 until his employment is terminated pursuant to
Section 9(b) offset, on a dollar-for-dollar basis, by any CRM provided insurance or social security
payments made to Executive relating to such disability.

8. Reimbursement of Business and Other Expenses.

Executive is authorized to incur reasonable expenses in carrying out his duties and
responsibilities under this Agreement, and CRM shall reimburse him for all such reasonable business
expenses, subject to documentation in accordance with CRM’s applicable policies.

9. Termination of Employment.

(a) Death. If Executive dies during the Term or any Renewal Term, Executive’s estate
and/or beneficiaries shall be entitled to (and their sole remedies under this Agreement shall be):

(i) Base Salary through the date of Executive’s death in a lump sum
within 10 days following the Date of Termination;

(ii) the balance of any incentive awards earned as of December 31 of
the prior year (but not yet paid), (together, with unpaid Base Salary,
“Accrued Amounts”) which incentive awards shall be paid in the form and at
the time the incentive awards are generally paid to employees of the
Company;

(iii) Pro Rata Annual Incentive for the year in which the date of
termination (“Termination Date”) occurs assuming Target performance (“Pro
Rata Annual Incentive”) which Pro Rate Annual Incentive shall be paid in a
lump sum within 10 days following the Date of Termination;

(iv) immediate vesting of all unvested and outstanding stock options,
(and the right to exercise all such stock options for one year), the removal
of any and all restrictions regarding any restricted stock or deferred stock
units, and the vesting and settlement of any performance awards at target
award levels (together, “Equity Acceleration”);and

(v) other or additional benefits then due or earned through the Date of
Termination in accordance with applicable plans and programs of CRM
(“Entitlements”).

(b) Disability. If as a result of Executive’s incapacity due to physical or mental
illness, Executive shall have been substantially unable to perform his duties hereunder for a
period of at least 120 consecutive days or 180 non-consecutive days within any 365-day period, the
Company shall have the right to terminate Executive’s employment hereunder for “Disability”, and
such termination in and of itself shall not be, nor shall it be deemed to be, a breach of this
Agreement or any law. In the event Executive’s employment is terminated for Disability, Executive
shall be entitled to (and his sole remedies under this Agreement shall be):

(i) his Accrued Amounts and his Pro Rata Annual Incentive;

(ii) reimbursement pursuant to Section 9 for reasonable expenses
incurred, but not paid to such termination of employment;

(iii) his Entitlements; and

(iv) Welfare Benefits.

(c) Termination by CRM for Cause.

(i) In the event a majority vote of the independent members of the
Board resolves to terminate Executive’s employment for Cause, Executive’s
sole remedies under this Agreement shall be to receive his Accrued Amounts
and any Entitlements through the date of termination. Executive shall not
be entitled to receive any Severance Pay (as defined) or Welfare Benefits
continuation, and his equity awards will be settled in accordance with the
terms and conditions of the applicable grant agreements.

(i) “Cause” shall mean Executive’s:

(A) breach of any of the material terms or covenants of this Agreement,
specifically including any breach of the covenants set forth in Sections 11,
12 or 13 of this Agreement;

(B) conviction of, or plea of nolo contendre to, any felony, or any act
that is materially and demonstrably injurious to CRM’s financial condition
or reputation;

(C) drug or alcohol use which impairs the ability of Executive to
perform his duties hereunder;

(D) engaging in conduct constituting gross neglect or willful
misconduct in carrying out his duties under this Agreement and that is
demonstrably injurious to CRM’s financial condition or CRM”S or Executive’s
reputation;

(E) act or omission of dishonesty, fraud, misrepresentation, conflict
of interest or breach of fiduciary duty;

(F) material failure to diligently, faithfully and competently perform
a substantial portion of Executive’s responsibilities, duties, or functions
as specified in this Agreement after 30 days advance written notice by CRM
and to the extent possible, a reasonable opportunity to cure by the
Executive;

(G) commission of any act or acts that harm the Company’s reputation,
standing or credibility within the communities it operates or with its
clients or suppliers; or

(H) act or series of acts constituting gross neglect and/or willful
misconduct resulting in a restatement of the Company’s financial statements
due to material non-compliance with any financial reporting requirement
within the meaning of Section 304 of The Sarbanes-Oxley Act of 2002.

(d) Voluntary Termination. In the event of a termination of employment by Executive
on his own initiative, which termination may be effective only 30 business days after delivery to
the Company of advance written notice of such termination, other than a termination due to death or
Disability, or by Executive for Good Reason, Executive shall be entitled to receive only his
Accrued Amounts and Entitlements.

(e) Termination by the Company without Cause or by Executive for Good Reason. If CRM
terminates Executive’s employment without Cause (which termination shall be effective as of the
date specified by CRM in a written notice to Executive), other than due to Executive’s death or
Disability, or if Executive terminates his employment for Good Reason (as defined below),
Executive’s sole remedies under this Agreement shall be to receive:

(i) his Accrued Amounts; a pro rata portion of the Annual Incentive
would have been paid for the full year in which the Termination Date occurs
based upon actual performance, payable at the time Annual Incentive payments
are generally paid to employees of the Company; his Entitlements, and
continuation of Welfare Benefits (to the extent permissible under the terms
of such plans and applicable law) for 18 months;

(ii) immediate vesting of all unvested and outstanding stock options
and the removal of any and all restrictions regarding any restricted stock
or deferred stock units, and

(iii) severance pay equal to the Base Salary amount immediately prior
to the Termination Date (unless a reduction in Base Salary is the reason for
a Good Reason termination, in which case, the Base Salary amount prior to
any such reduction) which severance pay shall be payable in 12 equal monthly
payments commencing within 10 days after the effective date of the release
provided for in Section 9(i) hereof.

(f) Termination due to Change in Control. In the event Executive’s employment is
terminated by the Company without cause or by Executive for good reason upon the occurrence of or
within six months following a Change in Control (as defined as below), Executive’s sole remedy
under this Agreement shall be to receive:

(i) his Accrued Amounts; a pro rata portion of the Annual Incentive
would have been paid for the full year in which the Termination Date occurs
based upon actual performance, payable at the time Annual Incentive payments
are generally paid to employees of the Company; his Entitlements, and
continuation of Welfare Benefits (to the extent permissible under the terms
of such plans and applicable law) for 12 months;

(ii) immediate vesting of all unvested and outstanding stock options
and the removal of any and all restrictions regarding any restricted stock
or deferred stock units, and;

(iii) severance pay equal to 200% of the base Salary immediately prior
to the Termination Date (unless a reduction in Base Salary is the reason for
a Good Reason termination, in which case, the Base Salary amount prior to
any such reduction), which severance pay shall be payable in 24 equal
monthly payments commencing within 10 days after the effective date of the
release provided for in Section 9(i) hereof.

(g) Certain definitions. For purposes of this Agreement, the following terms have the
meanings ascribed to them:

“CHANGE IN CONTROL” shall mean any of the following:

(i) any sale, lease, exchange or other transfer (in one or a series of
related transactions) of all or substantially all of the assets of the
Company;

(ii) any “person” as such term is used in Section 13(d) and Section
14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) is or becomes, directly or indirectly, the “beneficial owner” as
defined in Rule 13d-3 under the Exchange Act of securities of the Company
that represent 51% or more of the combined voting power of the Company’s
then outstanding voting securities;

(iii) during any period of two consecutive years, individuals who at
the beginning of such period constituted the Board (together with any new
directors whose election by the Board whose nomination by the shareholders
of the Company was approved by a vote of the Board then still in office who
are either directors at the beginning of such period or whose election or
nomination for election was so previously approved) cease for any reason to
constitute a majority of the Board then in office; or

(iv) the Board or the shareholders of the Company approve a merger or
consolidation of the Company with any other corporation, other than a
merger, amalgamation or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto continuing
to represent at least 50% of the total voting power represented by the
voting securities of the Company immediately after such merger, amalgamation
or consolidation, or the Board or shareholders of the Company approve a plan
of complete liquidation of the Company or an agreement for the sale or
disposition by the Company (in one or a series of transactions) of all or
substantially all of the Company’s assets.

“Good Reason” shall mean Executive’s termination of his employment with
CRM following the occurrence, without Executive’s written consent, of one or
more of the following events (except as a result of a prior termination):

(i) a material diminution or change, materially adverse to Executive’s
position, as set forth in Section 2(a);

(ii) any decrease in (i) Executive’s annual Base Salary, excluding a
decrease uniformly imposed on senior executive positions for reasons of
financial relief, or (ii) target Annual Incentive opportunity below 50% of
base salary; or

(iii) any other failure by CRM to perform any material obligation
under, or breach by CRM of any material provision of, this Agreement.
Notwithstanding the foregoing, prior to invoking termination for Good Reason
under subparagraphs (i) and (iii), CRM shall first be provided a 30 day cure
period from the date CRM received from Executive written notice specifying
the specific act or conduct constituting the failure and/or breach in issue
and CRM materially fails to effect such cure within the cure period.

(h) Mitigation and Offset. Executive has no obligation to mitigate payments due him
pursuant to this Agreement.

(i) Release of Employment Claims. As a condition to receipt of the payments and
benefits provided for in this Section 9 (other than Accrued Amounts and any Entitlements),
Executive agrees to execute a release, in a form reasonably satisfactory to CRM, releasing any and
all claims arising out of Executive’s employment (other than enforcement of this Agreement,
Executive’s rights under any of CRM’s incentive compensation and employee benefit plans and
programs, and any claim for any tort for personal injury not arising out of or related to his
termination of employment). Executive shall execute such release during the minimum period
required by law and receipt by CRM of such executed release shall be a condition precedent to CRM’s
obligation to make any payment to Executive hereunder.

10. Confidentiality; Litigation Cooperation; Non-disparagement.

(a) Confidentiality. During the Term and at all times thereafter, Executive shall not
disclose to anyone (except in good faith in the ordinary course of business to a person who will be
advised by Executive to keep such information confidential) or make use of any Confidential
Information except in the performance of his duties hereunder or when required to do so by legal
process, by any governmental agency having supervisory authority over the business of CRM or by any
administrative or legislative body (including a committee thereof) that requires him to divulge,
disclose or make accessible such information. In the event that Executive is so ordered, he shall
give prompt written notice to CRM to allow CRM the opportunity to object to or otherwise resist
such order.

For purposes of this Agreement, “Confidential Information” shall mean all information
concerning the business of CRM relating to any of their products, product development, trade
secrets, customers, suppliers, finances, and business plans and strategies. Excluded from the
definition of Confidential Information is information (i) that is or becomes part of the public
domain, other than through the breach of this Agreement by Executive or (ii) regarding CRM’s
business or industry properly acquired by Executive in the course of his career as an executive in
CRM’s industry and independent of Executive’s employment by CRM. For this purpose, information
known or available generally within the trade or industry of CRM shall be deemed to be known or
available to the public.

(b) Litigation Cooperation. Executive agrees to cooperate with CRM, during the Term
and thereafter (including following Executive’s termination of employment for any reason), by
making himself reasonably available to testify on behalf of CRM in any action, suit, or proceeding,
whether civil, criminal, administrative, or investigative, and to assist CRM, in any such action,
suit, or proceeding, by providing information and meeting and consulting with the Board or its
representatives or counsel, or representatives or counsel to CRM, as reasonably requested. CRM
agrees to reimburse Executive, on an after-tax basis, for reasonable expenses actually incurred in
connection with his provision of testimony or assistance.

(c) Non-Disparagement. Executive agrees that, during the Term and thereafter
(including following Executive’s termination of employment for any reason) he will not make
statements or representations, or otherwise communicate, directly or indirectly, in writing,
orally, or otherwise, or take any action which may, directly or indirectly, disparage the products,
services, or actions of CRM or any Affiliate, or it or their respective officers, directors,
employees, advisors, businesses or reputations provided, however, that Executive shall be permitted
to respond to any statements or communications by the directors and/or executive officers of CRM
which may directly or indirectly, disparage Executive, his business or reputation. However,
nothing in this Agreement shall preclude either of Executive or CRM from making truthful statements
or disclosures required by applicable law, regulation or legal process.

11. Non-competition.

(a) During the Restriction Period (as defined in Section 11(b) below), Executive shall not
engage in Competition with CRM or any Subsidiary. “Competition” shall mean engaging in any
activity ,directly or indirectly, for a Competitor of CRM or any Subsidiary, whether as an
employee, consultant, principal, agent, officer, director, partner, shareholder (except as a less
than one percent shareholder of a publicly traded company) or otherwise. A “Competitor” shall mean
any corporation or other entity which competes with the business conducted by CRM or any
Subsidiary, as determined on the date of termination of Executive’s employment. If Executive
commences employment or becomes a consultant, principal, agent, officer, director, partner, or
shareholder of any entity that is not a Competitor at the time Executive initially becomes employed
or becomes a consultant, principal, agent, officer, director, partner, or shareholder of the
entity, future activities of such entity shall not result in a violation of this provision unless
(x) such activities were contemplated by Executive at the time Executive initially became employed
or becomes a consultant, principal, agent, officer, director, partner, or shareholder of the entity
or (y) Executive commences directly or indirectly overseeing or managing the activities of an
entity which becomes a Competitor during the Restriction Period, which activities are competitive
with the activities of CRM. Executive shall not be deemed indirectly overseeing or managing the
activities of such Competitor which are competitive with the activities of CRM so long as he does
not regularly participate in discussions with regard to the conduct of the competing business.

(b) For the purposes of this Section 11, “Restriction Period” shall mean the period beginning
with the Effective Date and ending with the later of 12 months from the Termination Date or the
last day of the period during which the Executive is to receive severance payments.

(c) Reasonable Restrictions While the restrictions in Sections 10, 11 and 12 (on which the
Executive has had the opportunity to take independent advise of legal counsel, as the Executive
hereby acknowledges) are considered by the parties to be reasonable in all of the circumstances, it
is agreed that if any such restrictions, by themselves, or taken together, shall be adjudged to go
beyond what is reasonable in all the circumstances for the protection of the legitimate interests
of the Company but would be adjudged reasonable if part or parts of the wording thereof were
deleted, the relevant restriction or restrictions shall apply with such deletion(s) as may be
necessary to make it or them valid and effective.

12. Non-solicitation.

During the Restriction Period, Executive shall not induce employees of CRM to terminate their
employment, nor shall Executive solicit or encourage any of CRM’s customers, or any corporation or
other entity in a joint venture relationship (directly or indirectly) with CRM, to terminate or
diminish their relationship with CRM or to violate any agreement with any of them. During such
period, Executive shall not hire, either directly or through any employee, agent or representative,
any employee of CRM or any person who was employed by CRM within 180 days of such hiring.

13. Remedies.

If Executive breaches any of the provisions contained in Sections 10, 11 or 12 above, CRM (a)
shall have the right to immediately terminate all payments and benefits due under this Agreement
and (b) shall have the right to seek injunctive relief. Executive acknowledges that such a breach
of Sections 10, 11 or 12 would cause irreparable injury and that money damages would not provide an
adequate remedy for CRM; provided, however, the foregoing shall not prevent Executive from
contesting the issuance of any such injunction on the ground that no violation or threatened
violation of Section 10, 11 or 12 has occurred.

14. Resolution of Disputes.

Any controversy or claim arising out of or relating to this Agreement or any breach or
asserted breach hereof or questioning the validity and binding effect hereof arising under or in
connection with this Agreement, (other than seeking injunctive relief under Section 13), shall be
resolved by binding arbitration, to be held at an office closest to CRM’s principal offices in
accordance with the rules and procedures of the American Arbitration Association. Judgment upon
the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof.
All costs and expenses of any arbitration or court proceeding (including fees and disbursements of
counsel) shall be borne by the respective party incurring such costs and expenses. The arbitrator
or court may award reasonable costs and expenses to a party that substantially prevails in such
arbitration or court proceeding. Each party to this agreement hereby waives and shall not seek a
jury trial in any lawsuit, proceeding, claim, counterclaim, defense or other litigation or dispute
under or in respect of this agreement.

15. Indemnification.

(a) Company Indemnity. CRM agrees that if Executive is made a party, or is threatened
to be made a party, to any action, suit or proceeding, whether civil, criminal, administrative or
investigative (a “Proceeding”), by reason of the fact that he is or was a director, officer or
employee of CRM or is or was serving at the request of CRM as a director, officer, member, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise, including
service with respect to employee benefit plans, whether or not the basis of such Proceeding is
Executive’s alleged action in an official capacity while serving as a director, officer, member,
employee or agent, Executive shall be indemnified and held harmless by CRM to the fullest extent
legally permitted or authorized by CRM’s by-laws or resolutions of CRM’s Board or, if greater, by
the laws of the State of New York against all cost, expense, liability and loss (including, without
limitation, attorney’s fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or
to be paid in settlement) reasonably incurred or suffered by Executive in connection therewith, and
such indemnification shall continue as to Executive even if he has ceased to be a director, member,
officer, employee or agent of CRM or other entity and shall inure to the benefit of Executive’s
heirs, executors and administrators. CRM shall advance to Executive all reasonable costs and
expenses to be incurred by him in connection with a Proceeding within 20 days after receipt by CRM
of a written request for such advance. Such request shall include an undertaking by Executive to
repay the amount of such advance if it shall ultimately be determined that he is not entitled to be
indemnified against such costs and expenses. The provisions of this Section 15(a) shall not be
deemed exclusive of any other rights of indemnification to which Executive may be entitled or which
may be granted to him, and it shall be in addition to any rights of indemnification to which he may
be entitled under any policy of insurance.

(b) No Presumption Regarding Standard of Conduct. Neither the failure of CRM
(including its Board, independent legal counsel or shareholders) to have made a determination prior
to the commencement of any proceeding concerning payment of amounts claimed by Executive under
Section 15(a) above that indemnification of Executive is proper because he has met the applicable
standard of conduct, nor a determination by CRM (including its Board, independent legal counsel or
stockholders) that Executive has not met such applicable standard of conduct, shall create a
presumption that Executive has not met the applicable standard of conduct.

(c) Liability Insurance. CRM agrees to continue and maintain a directors and
officers’ liability insurance policy covering Executive to the extent CRM provides such coverage
for its other executive officers.

16. Miscellaneous.

(a) Other Benefits. Except as specifically provided in this Agreement, the existence
of this Agreement shall not be interpreted to preclude, prohibit or restrict Executive’s
participation in any other employee benefit or other plans or programs in which he currently
participates.

(b) Assignability; Binding Nature. This Agreement shall be binding upon and inure to
the benefit of the Parties and their respective successors, heirs (in the case of Executive) and
permitted assigns. No rights or obligations of CRM under this Agreement may be assigned or
transferred by CRM except that such rights or obligations may be assigned or transferred in
connection with the sale or transfer of all or substantially all of the assets of CRM, provided
that the assignee or transferee is the successor to all or substantially all of the assets of CRM
and such assignee or transferee assumes the liabilities, obligations and duties of CRM, as
contained in this Agreement, either contractually or as a matter of law. No rights or obligations
of Executive under this Agreement may be assigned or transferred by Executive other than his rights
to compensation and benefits, which may be transferred only by will or operation of law.

(c) Representation. CRM represents and warrants that it is fully authorized and
empowered to enter into this Agreement and that the performance of its obligations under this
Agreement will not violate any agreement between it and any other person, firm or organization.
Executive represents and warrants that the performance of his obligations under this agreement will
not violate any agreement between him and any other person, firm or organization.

(d) Entire Agreement. This Agreement shall become effective as of the Effective Date.
This Agreement contains the entire understanding and agreement between the Parties concerning the
subject matter hereof and, as of the Effective Date, supersedes all prior agreements,
understandings, discussions, negotiations and undertakings, whether written or oral, between the
Parties with respect thereto.

(e) Amendment or Waiver. No provision in this Agreement may be amended unless such
amendment is agreed to in writing and signed by Executive and an authorized officer of CRM. Except
as set forth herein, no delay or omission to exercise any right, power or remedy accruing to any
Party shall impair any such right, power or remedy or shall be construed to be a waiver of or an
acquiescence to any breach hereof. No waiver by either Party of any breach by the other Party of
any condition or provision contained in this Agreement to be performed by such other Party shall be
deemed a waiver of a similar or dissimilar condition or provision at the same or any prior or
subsequent time. Any waiver must be in writing and signed by Executive or an authorized officer of
CRM, as the case may be.

(f) Severability. In the event that any provision or portion of this Agreement shall
be determined to be invalid or unenforceable for any reason, in whole or in part, the remaining
provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect
to the fullest extent permitted by law.

(g) Survivorship. The respective rights and obligations of the Parties hereunder
shall survive any termination of Executive’s employment to the extent necessary to the intended
preservation of such rights and obligations.

(h) Beneficiaries/References. Executive shall be entitled, to the extent permitted
under any applicable law, to select and change a beneficiary or beneficiaries to receive any
compensation or benefit payable hereunder following Executive’s death by giving CRM written notice
thereof. In the event of Executive’s death or a judicial determination of his incompetence,
reference in this Agreement to Executive shall be deemed, where appropriate, to refer to his
beneficiary, estate or other legal representative.

(i) Governing Law/Jurisdiction. This Agreement shall be governed by and construed and
interpreted in accordance with the laws of New York without reference to principles of conflict of
laws. Subject to the provisions of Section 14 above, CRM and Executive hereby consent to the
jurisdiction of any or all of the following courts for purposes of resolving any dispute under this
Agreement: (i) the United States District Court for New York or (ii) any of the courts of the State
of New York. CRM and Executive further agree that any service of process or notice requirements in
any such proceeding shall be satisfied if the rules of such court relating thereto have been
substantially satisfied. CRM and Executive hereby waive, to the fullest extent permitted by
applicable law, any objection which it or he may now or hereafter have to such jurisdiction and any
defense of inconvenient forum.

(j) Notices. Any notice given to a Party shall be in writing and shall be deemed to
have been given when delivered personally or sent by certified or registered mail, postage prepaid,
return receipt requested, duly addressed to the Party concerned at the address indicated below or
to such changed address as such Party may subsequently give such notice of:

	 	 	 
	If to CRM:
	 	CRM Holdings, Ltd.

Skandia International House

40 Church Street

Hamilton HM 12 Bermuda

	If to Executive:
	 	Mr. Chester J. Walczyk

Address

Address

(k) Headings. The headings of the sections contained in this Agreement are for
convenience only and shall not be deemed to control or affect the meaning or construction of any
provision of this Agreement.

(l) Counterparts. This Agreement may be executed in two or more counterparts.

(m) Taxes and Withholdings; Section 409A. The payments and benefits to be made
pursuant to this Agreement shall be subject to all applicable withholdings for federal, state and
local income taxes, Social Security, and all other customary withholdings. The Company makes no
representations regarding the tax implications of the compensation, payments and benefits to be
paid to Executive under this Agreement. It is the intention of the parties that payments and
benefits under this Agreement be interpreted to be exempt from or in compliance with Section 409A
of the Internal Revenue Code of 1986, as amended (the “Code”) and accordingly, to the maximum
extent permitted, this Agreement shall be interpreted to be exempt from or in compliance with
Section 409A. Notwithstanding anything herein to the contrary, if (i) at the time of Executive’s
“separation from service” (as defined in Treas. Reg. Section 1.409A-1(h)) with CRM other than as a
result of his death, (ii) Executive is a “specified employee” (as defined in Section
409A(a)(2)(B)(i)), (iii) one or more of the payments or benefits received or to be received by
Executive pursuant to this Agreement would constitute deferred compensation subject to Section
409A, and (iv) the deferral of the commencement of any such payments or benefits otherwise payable
hereunder as a result of such separation of service is necessary in order to prevent any
accelerated or additional tax under Section 409A, then CRM will defer the commencement of the
payment of any such payments or benefits hereunder to the extent necessary (without any reduction
in such payments or benefits ultimately paid or provided to Executive) until the date that is six
months following Executive’s separation from service with CRM (or the earliest date as is permitted
under Section 409A of the Code). Any payment deferred during such six-month period shall be paid
in a lump sum on the day following such six-month period. Any remaining payments or benefits shall
be made as otherwise scheduled under this Agreement. Furthermore, to the extent any other payments
of money or other benefits due to Executive hereunder could cause the application of an accelerated
or additional tax under Section 409A, such payments or other benefits shall be deferred if deferral
will make such payment or other benefits compliant under Section 409A, or otherwise such payment or
other benefits shall be restructured, to the extent possible, in a manner determined by CRM that
does not cause such an accelerated or additional tax. To the extent any reimbursements or in-kind
benefits due to Executive under this Agreement constitute deferred compensation under Section 409A
of the Code, any such reimbursements or in-kind benefits shall be paid to Executive in a manner
consistent with Treas. Reg. Section 1.409A-3(i)(1)(iv). Each payment made under this Agreement
shall be designated as a “separate payment” within the meaning of Section 409A.

(n) Parachute Payments. Notwithstanding anything herein to the contrary, in the event
that Executive would otherwise have received any payments or distributions, whether payable or
distributed or distributable pursuant to the terms of this Agreement or otherwise, that constitute
“parachute payments” within the meaning of Section 280G of the Code (the “Parachute Payments”),
Executive shall receive the greater net after-tax amount (taking into account all applicable taxes
payable by Executive, including any excise tax imposed under Section 4999 of the Code (the “ Excise
Tax”)) of (i) the Parachute Payments and (ii) an amount equal to the Parachute Payments reduced by
the smallest amount necessary to take the Parachute Payments under the Excise Tax threshold.

1

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first written
above.

CRM HOLDINGS, LTD

By:/s/ Charles I. Johnston      

Name: Charles I. Johnston

Title: Member, Compensation Committee

By:/s/ Chester J. Walczyk—

Name: Mr. Chester J. Walczyk

2

EXHIBIT A

Defined Terms

	(a)	 	“Accrued Amounts” has the meaning set forth in Section 9(a).

	(b)	 	“Base Salary” has the meaning set forth in Section 3.

	(c)	 	“Cause” shall have the meaning set forth in Section 9(c).

	(d)	 	“Change in Control” shall have the meaning set forth in Section 9(f).

	(e)	 	“Company” shall have the meaning set forth in the first paragraph of the agreement.

	(f)	 	“Compensation Committee” has the meaning set forth in Section 3.

	(g)	 	“Competitor” or “Competition” has the meaning set forth in Section 11(a).

	(h)	 	“Confidential Information” has the meaning set forth in Section 10(a).

	(i)	 	“Disability” has the meaning set forth in Sections 7 and 9(b).

	(j)	 	“Entitlements” has the meaning set forth in Section 9(a).

	(k)	 	“Equity Acceleration” shall have meaning set forth in Section 9(a).

	(l)	 	“Good Reason” has the meaning set forth in Section 9(g).

	(m)	 	“Proceeding” has the meaning set forth in Section 15(a).

	(n)	 	“Pro Rata Annual Incentive” has the meaning set forth in Section 9(a).

	(o)	 	“Restriction Period” has the meaning set forth in Section 11(b).

	(p)	 	“Stock” means the common shares of CRM, par value $0.01 per share.

	(q)	 	“Target” means the target level of performance and associated Annual Incentive designated by
the Compensation Committee with respect to Executive for that relevant operating period.

	(r)	 	“Term” has the meaning set forth in Section 1.

	(s)	 	“Termination Date” has the meaning set forth in Section 9(a).

	(t)	 	“Welfare Benefits” has the meaning set forth in Section 6.

3ex-10_1.htm

Execution Copy

Fund Holdings LLC

December 23, 2009

Bonds.com Group, Inc.

1515 Federal Highway

Suite 212

Boca Raton, Florida 33432

 

Gentlemen:

 

Reference is made herein to that certain Unit Purchase Agreement, dated as of August 28, 2009 (as amended, the “UPA”), between Bonds.com Group, Inc. (the “Company”) and Fund Holdings
LLC (“Fund Holdings” and, together with the Company, the “Parties”).  Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the UPA.

 

The Parties wish to make certain amendments to the UPA as described in this amendment letter (this “Amendment Letter”).  Accordingly, the Parties hereby agree as follows:

 

	
  
	
1.
	
With respect to the 5,000 Units to be purchased by Fund Holdings pursuant to the UPA (the “Original 5,000 Units”), Fund Holdings may purchase (“Fund Holdings Investments” or arrange and coordinate the direct purchase by one or more other investors (“Direct
Investments”) of all or any portion of the remaining unpurchased Original 5,000 Units and up to an additional 2,000 Units (the “Additional 2,000 Units”) on substantially the same terms and conditions as set forth in the UPA (except as provided in paragraph 2 below and that any Fund Holdings Investments shall be on the same terms as set forth in the UPA); provided that,
if the Company’s Board of Directors  determines, in good faith, that the terms and conditions of any Direct Investment are not substantially the same terms and conditions as set forth in the UPA (after giving effect to paragraph 2 below), the Company shall not be obligated to accept any such Direct Investments; provided, however, that in no event shall Fund Holdings
Investments exceed the purchase of 5,000 Units (including those Units purchased prior to the date hereof).

 

	
  
	
2.
	
With respect to any Direct Investments: (a) such Direct Investments will be credited against Fund Holdings’ obligation to purchase the Original 5,000 Units for purposes of determining whether (i) the Additional Purchase Rights have terminated pursuant to Section 1(b)(iv) of the UPA, (ii) Fund Holdings has satisfied its obligations under Section 1(a)(ii)(C) of the UPA, and (iii) certain covenants of the Company
have terminated pursuant to Section 5(l) of the UPA; (b) subject to the provisos in paragraph 1 above, each Unit sold to investors making Direct Investments shall consist of 2,667 shares of Common Stock and 7,200 Ordinary Purchase Rights; (c) simultaneously with the closing of any Direct Investment, with respect to each Unit purchased in any Direct Investment, Fund Holdings shall have the right to purchase an amount of Ordinary Purchase Rights equal to the product of (i) 2,397, multiplied by a fraction, the numerator
of which is the number of Ordinary Purchase Rights issued to the investor making the Direct Investment at that closing and the denominator of which is 7,200, for an original purchase price to Fund Holdings equal to $1 per Unit (all Ordinary Purchase Rights purchasable by Fund Holdings pursuant to in this clause (c) are referred to collectively herein as the “Additional OPRs”);
and (d) the Company shall issue the Additional Purchase Rights to Fund Holdings (or its designees or assigns) so long as 5,000 Units have been purchased by Fund Holdings or pursuant to Direct Investments.

  

  

  

 

 

	
  
	
3.
	
In addition to the existing conditions set forth in the UPA, the obligation of Fund Holdings to purchase all or any portion of the balance of the Original 5,000 Units that have yet to be purchased by Fund Holdings (the “Remaining Units”) is subject to the satisfaction, at or before the Third Closing (as defined below), of each of the following conditions,
provided that these conditions are for Fund Holdings’ sole benefit and may be waived by Fund Holdings at any time in its sole discretion by providing the Company with prior written notice thereof:

 

	
  
	
a)
	
The Board of Directors of the Company shall have approved a resolution recommending that the Company’s stockholders vote to amend the Company’s Certificate of Incorporation to increase the number of authorized shares of Common Stock to 300,000,000 (the “Charter Amendment”) and obtained from the Company’s stockholders a valid written
consent approving the Charter Amendment, subject to compliance with applicable laws;

 

	
  
	
b)
	
Michael Sanderson (“Sanderson”) shall have been appointed as Co-chairman of the Board of Directors of the Company;

 

	
  
	
c)
	
Edwin L. Knetzger, III (“Knetzger”) shall have been appointed as Co-chairman of the Board of Directors of the Company;

 

	
  
	
d)
	
Sanderson shall have been appointed, for a three-year term, subject to removal only for cause, as the Chief Operating Officer of the Company’s New York office and as Chief Operating Officer of the Company’s Bondstation Pro line of business (if and to the extent permitted by applicable laws and regulations) or such other executive office of the Company
that is reasonably acceptable to Sanderson and Knetzger and is permitted under applicable laws and regulations;

 

	
  
	
e)
	
The Company and/or its Subsidiaries shall have obtained from InterDealer Securities, LLC, InterDealer Information Technologies, LLC and InterDealer IP Holding LLC (collectively, “Licensor”) an amendment, in a form satisfactory to Fund Holdings, to the existing license agreement between the Company and its Subsidiaries and Licensor with respect to
all present and future intellectual property rights owned or controlled by Licensor that is used or contemplated to be used by the Company in its products;

 

	
  
	
f)
	
The Company shall have executed and delivered an amended Revenue Sharing Agreement between Radnor Research and Trading, LLC and the Company;

  

  

  

 

	
  
	
g)
	
The Company shall have executed and delivered an employment agreement with George O’Krepkie (in a form satisfactory to Fund Holdings);

 

	
  
	
h)
	
The Company shall have executed and delivered a financial advisory agreement between the Company and The Fund LLC;

 

	
  
	
i)
	
The Company shall have received a consent, in a form satisfactory to Fund Holdings, of MBRO Capital, LLC (“MBRO”) pursuant to the Commercial Term Loan Agreement, dated March 31, 2009, by and between the Company and MBRO, to the issuance of the Securities pursuant to the UPA (as amended hereby);

 

	
  
	
j)
	
The Company shall have delivered to legal counsel for Fund Holdings and/or any person making a Direct Investment, as applicable, all stock certificates and rights certificates to be issued by the Company in connection with the Third Closing (such stock and rights certificates will be held in escrow by such counsel until the time of the Third Closing); provided that,
if Fund Holdings or any person making a Direct Investment does not notify the Company as to the amount of such person’s investment at least one business day prior to the Third Closing, the Company may deliver the stock and rights certificates issuable to the applicable person on or before the third business day following the Third Closing; and

 

	
  
	
k)
	
The Company shall have executed and delivered option grant agreements with respect to the option grants required under the UPA.

 

	
  
	
4.
	
Fund Holdings acknowledges and agrees that, so long as no event, change, circumstance, occurrence, effect or state of facts that could reasonably be expected to have a Material Adverse Effect has arisen since the date of this Amendment Letter or is disclosed or discovered after the date of this Amendment Letter, no later than the first business day following the satisfaction of the conditions set forth in Paragraph
3 above, Fund Holdings shall purchase (or cause the purchase through Direct Investments of) the Remaining Units (the “Third Closing”).

 

	
  
	
5.
	
Fund Holdings agrees that, if the Third Closing occurs, the certificates for the Additional Purchase Rights and such number of the Ordinary Purchase Rights as may be necessary under applicable law (but not to exceed 29,000,000) may include a provision that prohibits the exercise of such Additional Purchase Rights or Ordinary Purchase Rights, as applicable, until the Charter Amendment has become effective under applicable
law.

 

	
  
	
6.
	
The Company acknowledges and agrees that, except as otherwise agreed to by Fund Holdings, the Company will make the payment to Radnor Research & Advisory Co., LLC (as contemplated in Section 8(a)(i) of the Amended UPA) with respect to any Direct Investments.

 

	
  
	
7.
	
The Company covenants and agrees that, as soon as practicable, and in any event within 90 days after the Third Closing, the Company shall increase the size of the Board of Directors to six directors and appoint an additional independent director (who must be reasonably acceptable to Sanderson and Knetzger) to the Board of Directors and also
appoint such person to the Audit Committee of the Board of Directors.

  

  

  

 

 

	
  
	
8.
	
With respect to the Charter Amendment, the Company covenants and agrees that (i) promptly following the Third Closing (and in any event, within ten (10) business days thereafter), the Company shall prepare and file with the Securities and Exchange Commission (“SEC”) a 14C Information Statement advising the Company’s stockholders of the Charter
Amendment (the “Information Statement”), (ii) the Company shall use its best efforts to cause the Information Statement to be mailed to the stockholders of the Company as promptly as practicable after the Information Statement is approved by the SEC and, in any event, within 40 days following the Third Closing, (iii) the Company shall take any action required to be taken under any applicable state securities laws in connection with the issuance
of the Units and (iv) neither the Board of Directors of the Company nor any committee thereof shall withdraw (or modify in a manner adverse to Fund Holdings in any material respect), or publicly propose to withdraw (or modify in a manner adverse to Fund Holdings in any material respect), the Information Statement.  Notwithstanding the foregoing, prior to filing the Information Statement (or any amendment or supplement thereto) or responding to any comments of the SEC or its staff with respect thereto,
the Company (a) shall provide Fund Holdings an opportunity to review and comment on such document or response, (b) shall include in such document or response all comments reasonably proposed by Fund Holdings, and (c) shall not file or mail such document or respond to the SEC prior to receiving the approval of Fund Holdings, which approval shall not be unreasonably withheld.  If at any time prior to the effectiveness of the Charter Amendment, any information relating to the Company, Fund
Holdings, or any of their respective Affiliates, directors or officers, should be discovered by the Company or Fund Holdings which should be set forth in an amendment or supplement to the Information Statement, so that the Information Statement would not include any misstatement of material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they are made, not misleading, the party which discovers such information shall promptly notify the
other party and an appropriate amendment or supplement describing such information shall be promptly filed with the SEC and, to the extent required by applicable law or the SEC, disseminated to the stockholders of the Company.  The Company shall notify Fund Holdings promptly of the time when the Information Statement has been cleared by the SEC or of the receipt of any comments from the SEC or the staff of the SEC for amendments or supplements to the Information Statement for additional information
and shall supply Fund Holdings with copies of (x) all correspondence between the Company or any of its representatives, on the one hand, and the SEC or staff of the SEC, on the other hand, with respect to the Information Statement or the Unit Purchase Agreement and (y) all orders of the SEC relating to the Information Statement.

 

	
  
	
9.
	
As a condition to its willingness to enter into this Amendment Letter, Fund Holdings has required that, concurrent with the execution hereof, each of Mr. John J. Barry, III and Mr. John J. Barry, IV shall have executed and delivered to Fund Holdings the Voting Agreement in the form attached hereto as Exhibit A.

  

  

  

 

	
  
	
10.
	
All Ordinary Purchase Rights (including the Additional OPRs), Special Purchase Rights and Additional Purchase Rights whether heretofore or hereafter issued, shall include a cashless exercise feature.

 

	
  
	
11.
	
Except as otherwise provided herein, the provisions of the UPA shall remain in full force and effect with no changes other than those set forth in this Amendment Letter.

 

	
  
	
12.
	
This Amendment Letter may be executed in two or more counter­parts, each of which shall be deemed an original and all of which together shall constitute one instrument.

 

[Signature Pages Follow]

  

  

  

 

If the Company is in agreement with the foregoing, please sign and return to Fund Holdings a counterpart of this Amendment Letter, whereupon the terms hereof will become a binding agreement between the Parties.

	  	  	
FUND HOLDINGS LLC

	  	  	  
	  	  	
By:
	  
	  	  	
Name:
	
Edwin L. Knetzger, III

	  	  	
Title:
	
Manager

Please execute where so indicated below acknowledging your understanding of, and agreement with, the terms of this Amendment Letter.

BONDS.COM GROUP, INC.

By: ______________________

Authorized Signatory

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]